Computational Engineering of Major Allergens to Reduce Allergenicity and Maintain Immunogenicity Enables Safe and Effective Immunotherapy for Food Allergy
Inferring Disease Mechanisms in Lupus Nephritis: lessons from the Accelerating Medicines Partnership (AMP) in SLE Consortium
Location: Salon 8
Presenting Author: Arnon Arazi, PhD – The Feinstein Institutes for Medical Research
Autoimmune Diseases
3:45 PM – 4:00 PM PT
High Dimensional, Single Cell Analysis of Epstein Barr Virus (EBV)-Specific T Cells from Pediatric Transplant Recipients with EBV Dnaemia or Controlled Infection
Single-cell RNA-seq Analysis of PBMCs of Three Cameroonian Populations Reveals Differences in Cell Type Distribution as Well as Differentially Expressed Genes
Repeated Exposure to SARS-CoV-2 Antigens Induces Exceptionally Broad and Potent Neutralizing Immunity to Major Sarbecoviruses in Humans Including SARS-CoV-1
Combinatory Differentiation of Human Induced Pluripotent Stem Cells Generates Thymic Epithelium That Supports Thymic Crosstalk and Directs Dendritic- and CD4/CD8 T Cell Full Development
Patient-derived Lung Cancer Organoids as 3d-testing Platform for Advanced Personalized Therapies
Location: Salons 3-6
Presenting Author: Martí Farrera-Sal, PhD – Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT)
Oral
2:20 PM – 2:45 PM PT
Exploiting Artificial Thymic Organoids for the Modeling of Human FOXP3+ Regulatory T Cell Development
Tolerogenic IL-2 Containing Nanoparticles Induce CD4 and CD8 Regulatory T Cells and TGF-β Producing Regulatory NK Cells That Provide Essential Support for the Tregs Which Suppress Immune-mediated Disorders
Unique Aspects of IFN-γ/STAT1 Signaling in Neurons
Location: Salon 8
Speaker: Anthony Filiano, PhD – Duke University, Marcus Center for Cellular Cures
3:05 PM – 3:20 PM PT
Greater Composite Confirmed Disability Progression in Non-Hispanic Black and Hispanic or Latino Individuals with Relapsing Multiple Sclerosis: Analysis of Self-reported Identity and Genetic Ancestry in the OPERA I and II Trials